Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
about
Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and TreatmentCurrent Diagnostic and Therapeutic Aspects of Eosinophilic MyocarditisIntrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysisPredictors of Extracorporeal Membrane Oxygenation Support for Children with Acute MyocarditisAIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.Heart Failure in Chronic Myocarditis: A Role for microRNAs?Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-γ-Lyase/Hydrogen Sulfide PathwayStandard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.Unveiling nonischemic cardiomyopathies with cardiac magnetic resonance.Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.[Inflammatory cardiomyopathy and myocarditis].Role of coxsackievirus and adenovirus receptor (CAR) expression and viral load of adenovirus and enterovirus in patients with dilated cardiomyopathy.Pericardial diseases in the era of imaging, biomarkers and molecular diagnosis.Pericardioscopy and epi- and pericardial biopsy - a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy.Eosinophilic myocarditis as a first presentation of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure.Exercise and sports in cardiac patients and athletes at risk: Balance between benefit and harm.Acute fulminant necrotizing eosinophilic myocarditis: early diagnosis and treatment.[The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?].Myocardial homing of mesenchymal stem cells following intrapericardial application and amplification by inflammation - an experimental pilot study.Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulinsViral genome changes and the impact of viral genome persistence in myocardium of patients with inflammatory cardiomyopathy
P2860
Q26744257-6E69FB31-81FD-45F6-94DE-DD03DE6794A5Q26765206-AE66E509-E3A5-4128-B9FF-184AFA692B2AQ27310275-C3FDDF36-EB03-450A-BB10-D8AD532C0373Q33726293-ED930618-84E5-407A-8D0F-645AEC63276FQ33774747-CA8A771F-B76B-44FF-8E43-EEEB580CF4F8Q35742151-9539AB92-4887-4B94-97BE-98172CED30CDQ36359696-E3EEC83C-358A-43B0-9BBA-EBC516F9B6ABQ38066111-B6DAD823-8845-4A2E-8004-9D14E1250DA6Q38177854-D6E5C824-9DAE-4EF8-B02C-C02B9160FB6FQ38203822-9CA259CB-AEE3-4254-AFAA-07B4708F53C3Q40224028-2A997773-0E23-4A2B-B2FE-192F738980F5Q40413361-2BC7C70B-536E-44F1-BEF0-6B6D6B993481Q45902349-9980EA34-BEBE-436A-A4D7-9E08ADFE1614Q46558033-80F447B0-9FFF-4BCE-847E-43C4C14E7143Q47114877-CA2162E8-DB8A-4BFB-B62E-4863AC43ACA7Q47998095-386536FA-3B6B-4897-A82C-358126DAC443Q49126226-78BE3352-13CB-42AC-A0EC-6220AEE466C9Q49695907-A69E9614-C946-4373-87A1-9C3614FACB4FQ50456914-B5448D40-58DC-4EE3-9F40-62B8FA3E575EQ54088669-E4485694-5341-44BA-8683-E63CCF16ABFFQ56924750-F4A796EA-2CD3-4B34-ABAD-D0C04557FC8EQ58588572-98225E17-42F1-4B70-B0F1-076AF0AD4C31
P2860
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
@en
type
label
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
@en
prefLabel
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
@en
P2860
P1433
P1476
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
@en
P2093
P2860
P304
P356
10.1007/S00059-012-3679-9
P577
2012-09-01T00:00:00Z